Cargando…

CD44: A metastasis driver and therapeutic target

Detalles Bibliográficos
Autores principales:	Sottnik, Joseph L., Theodorescu, Dan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5235920/ https://www.ncbi.nlm.nih.gov/pubmed/28105456 http://dx.doi.org/10.18632/oncoscience.335

Ejemplares similares

CD44 as a tumor biomarker and therapeutic target
por: Xu, Hanxiao, et al.
Publicado: (2020)

CD44 Glycosylation as a Therapeutic Target in Oncology
por: Liao, Chengcheng, et al.
Publicado: (2022)

CD44 and RHAMM are essential for rapid growth of bladder cancer driven by loss of Glycogen Debranching Enzyme (AGL)
por: Oldenburg, Darby, et al.
Publicado: (2016)

Understanding Hyaluronan Receptor (CD44) Interaction, HA-CD44 Activated Potential Targets in Cancer Therapeutics
por: Chaudhry, Gul-e-Saba, et al.
Publicado: (2021)

Cancer Metastasis: A Therapeutic Target
por: Rajendran, Peramaiyan, et al.
Publicado: (2019)

The emerging role of CD44 in regulating skeletal metastasis
por: Hill, A, et al.
Publicado: (2006)

The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer
por: Thapa, Ranjeeta, et al.
Publicado: (2016)

Editorial
por: Lerner, Seth P., et al.
Publicado: (2015)

New Sister Journal Kidney Cancer
por: Lerner, Seth P., et al.
Publicado: (2017)

CD74 and CD44 Expression on CTCs in Cancer Patients with Brain Metastasis
por: Loreth, Desiree, et al.
Publicado: (2021)

Targeting CD44 as a novel therapeutic approach for treating pancreatic cancer recurrence
por: Molejon, Maria Inés, et al.
Publicado: (2015)

Prevention of tumor metastasis formation by anti-variant CD44
Publicado: (1993)

Role of Versican, Hyaluronan and CD44 in Ovarian Cancer Metastasis
por: Ween, Miranda P., et al.
Publicado: (2011)

CD44 increases the efficiency of distant metastasis of breast cancer
por: McFarlane, Suzanne, et al.
Publicado: (2015)

Therapeutic targeting of alternative splicing to inhibit hepatocellular carcinoma metastasis
por: Lee, Yun-Han
Publicado: (2022)

CD44v8-10 is a marker for malignant traits and a potential driver of bone metastasis in a subpopulation of prostate cancer cells
por: Fontanella, Rosaria A., et al.
Publicado: (2021)

Radiation resistance in breast cancer: are CD44(+)/CD24(-)/proteosome(low)/PKH26(+ )cells to blame?
por: Nakshatri, Harikrishna
Publicado: (2010)

GM-CSF - an oncogenic driver of HER2+ breast leptomeningeal metastasis
por: Garg, Rachana, et al.
Publicado: (2022)

Preclinical Identification of Sulfasalazine’s Therapeutic Potential for Suppressing Colorectal Cancer Stemness and Metastasis through Targeting KRAS/MMP7/CD44 Signaling
por: Leung, Wai-Hung, et al.
Publicado: (2022)

Targeting Oncoimmune Drivers of Cancer Metastasis
por: Kudo-Saito, Chie, et al.
Publicado: (2021)

Simultaneous targeting of CD44 and MMP9 catalytic and hemopexin domains as a therapeutic strategy
por: Yosef, Gal, et al.
Publicado: (2021)

CD44-Targeted Nanocarrier for Cancer Therapy
por: Kesharwani, Prashant, et al.
Publicado: (2022)

RhoGDI2 suppresses bladder cancer metastasis via reduction of inflammation in the tumor microenvironment
por: Said, Neveen, et al.
Publicado: (2012)

miR-302a Inhibits Metastasis and Cetuximab Resistance in Colorectal Cancer by Targeting NFIB and CD44
por: Sun, Lina, et al.
Publicado: (2019)

CD44 and xCT: The Silver Bullet for Endothelial-to-Mesenchymal Transition in Pulmonary Arterial Hypertension?
por: Agrawal, Vineet, et al.
Publicado: (2019)

CD44 Acts as a Signaling Platform Controlling Tumor Progression and Metastasis
por: Orian-Rousseau, Véronique
Publicado: (2015)

Association of human breast cancer CD44(-)/CD24(-) cells with delayed distant metastasis
por: Qiao, Xinbo, et al.
Publicado: (2021)

Thyroid Cancer: Focus on Invasion and Metastasis Mechanisms, Therapeutic Target and Drug Treatment
por: Vasko, Vasyl
Publicado: (2023)

The biology and role of CD44 in cancer progression: therapeutic implications
por: Chen, Chen, et al.
Publicado: (2018)

The fibrotic and immune microenvironments as targetable drivers of metastasis
por: Boulter, Luke, et al.
Publicado: (2020)

Inflammation as a Driver of Prostate Cancer Metastasis and Therapeutic Resistance
por: Archer, Maddison, et al.
Publicado: (2020)

The Role of CD44 in Disease Pathophysiology and Targeted Treatment
por: Jordan, Andre R., et al.
Publicado: (2015)

Association of CD44 Gene Polymorphism with Survival of NSCLC and Risk of Bone Metastasis
por: Liu, Yaosheng, et al.
Publicado: (2015)

Single-cell transcriptomics reveals the drivers and therapeutic targets of lymph node metastasis in lung adenocarcinoma
por: Ji, Xin, et al.
Publicado: (2023)

Targeting CD44 Variant 5 with an Antibody–Drug Conjugate Is an Effective Therapeutic Strategy for Intrahepatic Cholangiocarcinoma
por: Bei, Yuncheng, et al.
Publicado: (2023)

Prognostic value of CD133(+) CD54(+) CD44(+) circulating tumor cells in colorectal cancer with liver metastasis
por: Fang, Chao, et al.
Publicado: (2017)

The liberation of CD44
por: Cichy, Joanna, et al.
Publicado: (2003)

STAT3 as a potential therapeutic target in ALDH(+) and CD44(+)/CD24(+) stem cell-like pancreatic cancer cells
por: Lin, Li, et al.
Publicado: (2016)

Deciphering the cellular source of tumor relapse identifies CD44 as a major therapeutic target in pancreatic adenocarcinoma
por: Molejon, Maria Inés, et al.
Publicado: (2015)

CD44s and CD44v6 Expression in Head and Neck Epithelia
por: Mack, Brigitte, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_k3al7a5j3goh1mu08mri3pq32e